Entrada Therapeutics Inc. (TRDA)
NASDAQ: TRDA
· Real-Time Price · USD
8.04
-0.20 (-2.43%)
At close: Jun 04, 2025, 3:40 PM
Entrada Therapeutics Revenue
Entrada Therapeutics reported an annual revenue of $210.78M, reflecting a 63.38% growth. For the quarter ending March 31, 2025, Entrada Therapeutics generated $20.56M in revenue.
Revenue (ttm)
$210.78M
Revenue Growth
63.38%
Price / Sales Ratio
3.06
Revenue / Employee
$1.15M
Employees
183
Market Cap
304.96M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|